Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 7/20 | 0.51 |
| ▸ | MAPT | P10636 | 5/20 | 0.51 |
| ▸ | LMNA | P02545 | 3/20 | 0.51 |
| ▸ | HTT | P42858 | 3/20 | 0.51 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.49 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | TP53 | P04637 | 1/20 | 0.49 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | BRD9 | Q9H8M2 | 1/20 | 0.46 |
| ▸ | METAP1 | P53582 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2880191 | 0.89 | LMNA (0.54) | GAALMNAHTTHSP90AA1HSP90AB1 | |
| SCHEMBL5866194 | 0.85 | HSP90AA1 (0.46) | LMNAHTTHSP90AA1HSP90AB1POLB | |
| SCHEMBL38661613 | 0.84 | GAA (0.48) | GAAMAPTLMNAHTTHSP90AA1 | |
| SCHEMBL28697219 | 0.83 | RXFP1 (0.47) | GAAMAPTLMNAHTTHSP90AA1 | |
| SCHEMBL6241238 | 0.83 | TRPV1 (0.50) | GAAHSP90AA1HSP90AB1POLBKMT2A | |
| SCHEMBL10845357 | 0.83 | MAPT (0.47) | GAAMAPTLMNAHTTPOLB | |
| SCHEMBL2877719 | 0.83 | GAA (0.49) | GAAMAPTLMNAHTTPOLB | |
| SCHEMBL16774987 | 0.83 | GAA (0.52) | GAAMAPTLMNAHTTHSP90AA1 | |
| SCHEMBL29106089 | 0.82 | CA12 (0.47) | LMNAHSP90AA1HSP90AB1POLBRXFP1 | |
| SCHEMBL30087033 | 0.82 | HSP90AA1 (0.45) | GAAMAPTLMNAHSP90AA1HSP90AB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 91 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109485580-A | A kind of synthetic method of eltrombopag olamine intermediate | 武汉武药科技有限公司 | 2019-03-19 | — | — | CN | claimed |
| WO-2016142954-A2 | IMPROVED PROCESS FOR THE PREPARATION OF [3R,5R]-2-FLUOROPHENYL-β,δ- DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-[(2-HYDROXYPHENYLAMINO)- CARBONYL]-1H-PYRROLE-1-HEPTANOIC ACID, SODIUM SALT | MSN LABORATORIES PRIVATE LIMITED (IN) | 2016-09-15 | — | — | WO | claimed |
| US-20260137698-A1 | CYCLIN-DEPENDENT KINASE 7 INHIBITORS | JOINT STOCK CO «BIOCAD» (RU) | 2026-05-21 | — | — | US | disclosed |
| CN-122059992-A | AKR1C3 selectively activated small molecule drug conjugate and application thereof | 中国药科大学 | 2026-05-19 | — | — | CN | disclosed |
| CN-122036638-A | AKR1C3 inhibitor with tricyclic structure and application thereof | 中国药科大学 | 2026-05-15 | — | — | CN | disclosed |
| US-20250353874-A1 | GLUCOCORTICOID RECEPTOR AGONISTS | LILLY CO ELI (US) | 2025-11-20 | — | — | US | disclosed |
| US-12419976-B2 | Hybrid tracers for targeted cancer imaging and treatment | ACADEMISCH ZIEKENHUIS LEIDEN (H.O.D.N. LUMC) GMBH (NL) | 2025-09-23 | — | — | US | disclosed |
| US-12404298-B2 | Glucocorticoid receptor agonists | ELI LILLY AND COMPANY (US) | 2025-09-02 | — | — | US | disclosed |
| EP-4592283-A1 | CYCLIN-DEPENDENT KINASE 7 INHIBITORS | Joint Stock Company "Biocad" (RU) | 2025-07-30 | — | — | EP | disclosed |
| WO-2024126533-A1 | MULTIPLEXING TARGETING AND IMAGING AGENTS | ACADEMISCH ZIEKENHUIS LEIDEN (h.o.d.n. LUMC) (NL) | 2024-06-20 | — | — | WO | disclosed |
| EP-4314005-A1 | GLUCOCORTICOID RECEPTOR AGONISTS | Eli Lilly and Company (US) | 2024-02-07 | — | — | EP | disclosed |
| WO-2001000565-A1 | METHOD FOR PRODUCING ALKOXY ARYLAMINE COMPOUNDS | ALLIEDSIGNAL INC. (US) | 2001-01-04 | — | — | WO | disclosed |
| US-6054457-A | Benzamide derivatives and their use as vasopressin antagonists | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2000-04-25 | — | — | US | disclosed |
| CN-1247863-A | Carriers for combination of organic synthetic connecting material, their prepn. and use | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 2000-03-22 | — | — | CN | disclosed |
| EP-0985662-A2 | Linker binding carriers for organic synthesis, their production and use | Takeda Chemical Industries, Ltd. (JP) | 2000-03-15 | — | — | EP | disclosed |
| EP-0832061-A1 | BENZAMIDE DERIVATIVES AND THEIR USE AS VASOPRESSIN ANTAGONISTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1998-04-01 | — | — | EP | disclosed |
| EP-0595995-B1 | ARYLAMIDOALKYL- AND ARYLAMINOALKYL-N-HYDROXYUREA COMPOUNDS AND -N-HYDROXYFORMAMIDE DERIVATIVES HAVING LIPOXYGENASE INHIBITORY ACTIVITY | ABBOTT LAB (US) | 1997-01-15 | — | — | EP | disclosed |
| WO-1996041795-A1 | BENZAMIDE DERIVATIVES AND THEIR USE AS VASOPRESSIN ANTAGONISTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-12-27 | — | — | WO | disclosed |
| US-5514702-A | Arylamidoalkyl-N-hydroxyurea compounds having lipoxygenase inhibitory activity | ABBOTT LABORATORIES (US) | 1996-05-07 | — | — | US | disclosed |
| US-5214204-A | Inhibitors of biosynthesis of leukotrienes | ABBOTT LABORATORIES (US) | 1993-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12419976-B2 | Hybrid tracers for targeted cancer imaging and treatment | HNRNPF, ANXA3, SLC67A1 | GAA 100/4885MAPT 2016/4885LMNA 1700/4885 |
| US-12404298-B2 | Glucocorticoid receptor agonists | NR3C1, NR3C2, MC2R | GAA 4871/4885MAPT 3892/4885LMNA 4758/4885 |
| US-20260137698-A1 | CYCLIN-DEPENDENT KINASE 7 INHIBITORS | CDK7, CDK6, CDK3 | GAA 2822/4885MAPT 3889/4885LMNA 1547/4885 |
| US-20250353874-A1 | GLUCOCORTICOID RECEPTOR AGONISTS | NR3C1, NR3C2, MC2R | GAA 4871/4885MAPT 3892/4885LMNA 4758/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.